Efficacy of Therapeutic Exercise vs. Treatment of Myofascial Trigger Points.

February 2, 2024 updated by: JORGE VELAZQUEZ SAORNIL, Universidad Católica de Ávila

Efficacy of Therapeutic Exercise vs. Treatment of Myofascial Trigger Points in Shoulder Tendinopathies: Randomised Clinical Trial

Background: Shoulder pain commonly affects the general population, with rotator cuff tendinopathy being the most common cause.

the most common cause, with rotator cuff tendinopathy diminishing function and quality of life, leading to a major socio-economic impact.

quality of life, leading to a major socio-economic impact. As a result, there are two treatment approaches with potential effectiveness: therapeutic exercise (TE) and myofascial trigger point treatment (TMT).

trigger point treatment (TTP).

Objective: The main objective of this randomised clinical trial is to determine the efficacy of ET versus treatment of MTPs in shoulder tendinopathies.

Methods: For this study, 20 participants were randomly divided into two groups: a ET group, with which a 10-exercise programme was initiated (n = 10), and a PGM group which was given an intervention protocol (n = 10).

intervention protocol (n = 10). Both received a total of 10 sessions. Pain intensity pain intensity, pressure pain threshold (PPT) and range of motion (ROM) were assessed before starting and after 10 sessions.

and after 10 sessions.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Ávila, Spain, 05001
        • Jorge Velázquez Saornil

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Signed informed consent form.
  • Patients diagnosed by an orthopaedic surgeon with shoulder tendinopathy. tendinopathy.
  • Symptoms of shoulder pain lasting more than 3 months.
  • Pain on Jobe, Patte and infraspinatus assessment manoeuvres (highlighting abduction and abduction and external rotation).

Exclusion Criteria:

  • Previous shoulder surgery.
  • Radiating (non-referred) pain from cervical radiculopathy.
  • Shoulder pain associated with other diagnoses (Examples: retractile capsulitis, subacromial syndrome, tendon rupture, posterosuperior conflict, etc.).

subacromial syndrome, tendon rupture, posterosuperior conflict, etc).

  • Patients with multiple pathologies.
  • Patients with neurological disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: therapeutic exercise group
patients who have been treated for shoulder tendinopathy by exercise therapy
Procedure: Exercise therapy
patients who have been treated for shoulder tendinopathy by exercise therapy
Active Comparator: trigger points group
patients who have been treated for shoulder tendinopathy by trigger point therapy
Procedure: trigger point therapy
patients who have been treated for shoulder tendinopathy by trigger point therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of motion
Time Frame: At the end of Session 10 (each Session is 7 days)
measurement of shoulder range of motion
At the end of Session 10 (each Session is 7 days)
pain intensity
Time Frame: At the end of Session 10 (each Session is 7 days)
measured on a VAS scale where 0 is the minimum and 10 is the maximum.
At the end of Session 10 (each Session is 7 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pressure pain threshold
Time Frame: At the end of Session 10 (each Session is 7 days)
measured by algometer
At the end of Session 10 (each Session is 7 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Católica de Ávila

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2023

Primary Completion (Actual)

November 1, 2023

Study Completion (Actual)

January 15, 2024

Study Registration Dates

First Submitted

January 25, 2024

First Submitted That Met QC Criteria

February 2, 2024

First Posted (Estimated)

February 5, 2024

Study Record Updates

Last Update Posted (Estimated)

February 5, 2024

Last Update Submitted That Met QC Criteria

February 2, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 250124

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Tendinopathy

Clinical Trials on Exercise therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe